Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed Mar 20, 2015 · 10-K · 79 days after period end · 0001171843-15-001528
| Metric | Q4 2014 | Q4 2013 |
|---|---|---|
| Net Income | $7.23M | -$2.40M |
| EPS Diluted | $0.48 | -$16.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 20, 2015 · 79 d after period end
